7
Participants
Start Date
September 21, 2023
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
PPMX-T003
The therapeutic agent is administered continuously intravenously
RECRUITING
Hiroshima University Hospital, Hiroshima
Kyoto University Hospital
OTHER
Hokkaido University Hospital
OTHER
Okayama University
OTHER
Tokai University
OTHER
Kyushu University
OTHER
Tohoku University
OTHER
Nagoya University
OTHER
Komagome Hospital
OTHER
Hiroshima University Hospital
OTHER